Gastroenterology

Novo Nordisk announces Health Canada has granted priority review status for once-weekly semaglutide to treat metabolic dysfunction-associated steatohepatitis.

Get the info you need on this new drug, part of our drug news roundup for April.

Get the info you need on this new drug, part of our drug news roundup for April.

Recommendations also provided for hormone replacement therapy following preventive hysterectomy/bilateral salpingo-oophorectomy and daily ASA to prevent colon cancer.

New study examines association between statin use and the risk of hepatocellular carcinoma and hepatic decompensation in adults with chronic liver disease.

Large cohort study finds patients taking GLP-1 RAs undergoing common surgical procedures have no increased risk of postoperative aspiration pneumonia.

A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's and colitis.

Ferring’s Rebyota is indicated for the prevention of recurrence of Clostridioides difficile infection in adults, following antibiotic treatment for recurrent C. difficile.